Published in Eur Heart J on June 01, 1990
Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease. J Thromb Thrombolysis (1998) 0.80
Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis. Thromb J (2011) 0.77
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost (2004) 2.21
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet (2001) 2.15
Effect on blood lipids, coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. Am J Clin Nutr (1994) 2.12
Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr (2001) 1.84
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation (1996) 1.80
An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations. Am J Hum Genet (2001) 1.70
Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation. Lancet (1998) 1.47
A comparison of artificially-depleted, lyophilized coumarin and fresh coumarin plasmas in thromboplastin calibration. European Concerted Action on Anticoagulation. Br J Haematol (1998) 1.44
A simplified statistical method for local INR using linear regression. European Concerted Action on Anticoagulation. Br J Haematol (1997) 1.40
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study. J Am Coll Cardiol (1991) 1.39
Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) (2004) 1.30
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest (1985) 1.22
Are olive oil diets antithrombotic? Diets enriched with olive, rapeseed, or sunflower oil affect postprandial factor VII differently. Am J Clin Nutr (1999) 1.18
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb (1993) 1.14
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal. J Thromb Haemost (2013) 1.12
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21. Am J Hum Genet (1997) 1.11
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a rebuttal. J Thromb Haemost (2013) 1.10
Protein C activation during the initial phase of experimental acute pancreatitis in the rabbit. Dig Surg (1999) 1.06
Genetic influence on thrombotic risk markers in the elderly--a Danish twin study. J Thromb Haemost (2005) 1.02
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost (2008) 1.00
Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas (2000) 1.00
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res (1996) 0.96
European Concerted Action on Anticoagulation (ECAA)-the multicentre calibration of rabbit and human ECAA reference thromboplastins. Steering Committee. Thromb Haemost (1996) 0.96
Minimum lyophilized plasma requirement for ISI calibration. European Concerted Action on Anticoagulation. Am J Clin Pathol (1998) 0.95
The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studies. J Thromb Haemost (2011) 0.94
Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost (2000) 0.94
European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems. Br J Haematol (2002) 0.93
Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis (1990) 0.92
The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol (2000) 0.92
European Concerted Action on Anticoagulation (ECAA). An assessment of lyophilised plasmas for ISI calibration of CoaguChek and TAS whole blood prothrombin time monitors. J Clin Pathol (2003) 0.92
The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis (1992) 0.92
Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am J Clin Nutr (1994) 0.92
Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb Haemost (1999) 0.91
Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. J Bone Miner Res (2000) 0.91
The effect of sample size on fresh plasma thromboplastin ISI determination. Br J Haematol (1999) 0.90
European Concerted Action on Anticoagulation--comparison of fresh plasma and whole blood multicentre ISI calibrations of CoaguChek Mini and TAS PT-NC whole blood prothrombin time point-of-care monitors. Thromb Haemost (2002) 0.90
Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women. Maturitas (2001) 0.90
Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost (2003) 0.89
Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3. Am J Hum Genet (2001) 0.89
Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Intern Med (1991) 0.88
Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr (1994) 0.88
Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis. Br J Urol (1997) 0.88
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor. Hum Reprod (2002) 0.87
Switching from DXA pencil-beam to fan-beam. I: Studies in vitro at four centers. Bone (1995) 0.87
Autosomal dominant osteopetrosis: bone mineral measurements of the entire skeleton of adults in two different subtypes. Bone (1995) 0.87
Premenopausal smoking and bone density in 2015 perimenopausal women. J Bone Miner Res (2000) 0.86
Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study. J Thromb Haemost (2003) 0.86
Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women. Bone (1998) 0.85
A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. Haemostasis (1983) 0.85
Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Clin Nephrol (2000) 0.85
Effect of inhaled heparin on lung function and coagulation in healthy volunteers. Eur Respir J (2002) 0.84
Biological variation of serum and urinary magnesium in apparently healthy males. Scand J Clin Lab Invest (1995) 0.84
Report on the Dutch consensus development meeting for implementation and further development of population screening for colorectal cancer based on FOBT. Cell Oncol (2005) 0.84
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.84
Self-perceived facture risk: factors underlying women's perception of risk for osteoporotic fractures: the Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE). Osteoporos Int (2014) 0.83
Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study. J Intern Med (2000) 0.83
Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone (1995) 0.83
Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet (1995) 0.83
Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb (1993) 0.83
The importance of "like to like" ISI calibrations with freeze dried plasmas. European Concerted Action on Anticoagulation. J Clin Pathol (1998) 0.82
Fasting serum insulin levels and coronary heart disease in a Danish cohort: 17-year follow-up. J Cardiovasc Risk (1995) 0.82
Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol (1997) 0.82
Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study. Osteoporos Int (2010) 0.81
The European Concerted Action on Anticoagulation (ECAA) evaluation of a set of lyophilized normal plasmas to establish the normal prothrombin time for coagulometer systems. Thromb Haemost (1998) 0.81
Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Scand J Clin Lab Invest (2007) 0.81
Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Br J Urol (1997) 0.81
The European Concerted Action on Anticoagulation (ECAA): field studies of coagulometer effects on the ISI of ECAA thromboplastins. Thromb Haemost (1998) 0.81
Jet and ultrasonic nebulization of single chain urokinase plasminogen activator (scu-PA). J Aerosol Med (2000) 0.81
Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study. BJOG (2003) 0.81
Antithrombin-III and platelets in haemodialysis patients. Nephron (1981) 0.81
The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition. Thromb Res (1986) 0.81
[The effect of liver cirrhosis on activation of the coagulation and fibrinolysis system and on coagulation inhibitors]. Med Klin (Munich) (1989) 0.81
The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate. J Thromb Haemost (2013) 0.80
Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII. Arterioscler Thromb Vasc Biol (1997) 0.80
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction. Acta Med Scand (1987) 0.80
Serum levels of fetal antigen 2 in hyperthyroidism and primary hyperparathyroidism. APMIS (1992) 0.80
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium. J Intern Med (1990) 0.80
The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum. Scand J Clin Lab Invest (1995) 0.80
DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit? Thromb Haemost (1999) 0.80
High bone mineral apparent density in children with X-linked hypophosphatemia. Osteoporos Int (2013) 0.79
Chronic interstitial cystitis: increased levels of eosinophil cationic protein in serum and urine and an ameliorating effect of subcutaneous heparin. Scand J Urol Nephrol (1983) 0.79
Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study. Clin Endocrinol (Oxf) (1994) 0.79